CLU and Alzheimer disease: Nevertheless, this study allowed us to uncover a mechanism underlying reduced white matter integrity observed in the CLU rs11136000 risk “C” allele carriers, which can help us to develop AD therapies by targeting events upstream of myelination deficits.